Pulmonary Embolism
📧 Sign up to get email alerts when something new happens for Pulmonary Embolism.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: Evaluation of the PERC Score and the YEARS Algorithm in the Diagnosis of Pulmonary Embolism in the Emergency Department
A Strasbourg-based clinical trial is evaluating the accuracy of the PERC score and the YEARS algorithm for diagnosing pulmonary embolism in …
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: Safety and Efficiency of the YEARS Algorithm Versus Computed Tomography Pulmonary Angiography Alone for Suspected Pulmonary Embolism in Patients With Malignancy [NA]
This update reports the completed clinical trial comparing the YEARS diagnostic algorithm to CT pulmonary angiography for suspected pulmonar…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Using End-Tidal CO₂ to Help Diagnose and Monitor Pulmonary Embolism
A completed clinical trial from Ataturk University evaluating end-tidal CO2 as a diagnostic and monitoring tool for acute pulmonary embolism…
-
CLINICAL_TRIALS trial_result · 2025-12-18Clinical Trial Update: DOACT Algorithm Versus AI-Based Decision Models in Oral Anticoagulant Therapy for Vascular Patients [NA]
A completed study comparing the DOACT algorithm to AI-based decision models for guiding oral anticoagulant therapy in vascular conditions.
-
EMA approval · 2025-12-17EMA Authorised: Rivaroxaban Koanaa (rivaroxaban) — Koanaa Healthcare GmbH
The European Medicines Agency authorised Koanaa Healthcare GmbH's rivaroxaban product, Koanaa, for indications including venous thromboembol…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Duration of Therapeutic Anticoagulation in Patients With Pulmonary Embolism
Clinical trial update investigating the optimal duration of therapeutic anticoagulation for patients with pulmonary embolism; study currentl…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Safety and Effectiveness of the Akura Thrombectomy System for Use in the Removal of Emboli From the Pulmonary Arteries in Treating Acute Pulmonary Embolism (PE) [NA]
A clinical trial is evaluating the safety and effectiveness of the Akura Thrombectomy System for removing emboli from pulmonary arteries in …
-
CLINICAL_TRIALS research · 2025-12-09Clinical Trial Update: Cardiac point-of Care Ultrasound Training Pathway for Emergency Department Advanced Practice Providers [NA]
A clinical trial update indicates a Cardiac Point-of-Care Ultrasound training pathway for emergency department advanced practice providers i…
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: RIVAroxaban Versus Low-molecular Weight Heparin in Patients With Lower Limb Trauma Requiring Brace or CASTing [Phase 3]
A Phase 3 clinical trial comparing rivaroxaban to low-molecular-weight heparin for prevention of venous thromboembolism in patients with low…
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Non-immunogenic Recombinant Staphylokinase vs Placebo in Patients With Intermediate High-risk Pulmonary Embolism [Phase 3]
This clinical trial update describes a Phase 3 study comparing non-immunogenic recombinant Staphylokinase versus placebo in patients with in…
-
CLINICAL_TRIALS trial_result · 2025-12-03Clinical Trial Update: Efficacy of Intermittent Pneumatic Compression (IPC) on Venous Thromboembolism Incidence in Intensive Care Unit (ICU) Patients With High Bleeding Risk [Phase 3]
Phase 3 clinical trial evaluating the efficacy of intermittent pneumatic compression to reduce venous thromboembolism in ICU patients with h…
-
CLINICAL_TRIALS trial_result · 2025-12-03Clinical Trial Update: Ga68 V/Q PET/CT for Pulmonary Embolism Diagnosis: a Diagnostic Accuracy Study vs CT Pulmonary Angiography [NA]
A completed diagnostic accuracy study evaluated Ga68 V/Q PET/CT versus CT pulmonary angiography for diagnosing pulmonary embolism.
-
CLINICAL_TRIALS trial_result · 2025-12-03Clinical Trial Update: Pulmonary Perfusion by Iodine Subtraction Mapping CT Angiography in Acute Pulmonary Embolism [NA]
A clinical trial evaluating pulmonary perfusion using iodine subtraction mapping CT angiography for acute pulmonary embolism has completed.
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: Therapeutic Initial Heparin Dosing for Patients With Clots or Certain Heart Conditions Admitted to the Hospital [Phase 4]
Phase 4 clinical trial update evaluating the initial therapeutic dosing of heparin for hospitalized patients with clots or certain heart con…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: Post-registration Trial of the Non-immunogenic Staphylokinase in Massive Pulmonary Embolism
A post-registration trial of a non-immunogenic staphylokinase for massive pulmonary embolism is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-11-21Clinical Trial Update: Free DNA and Nucleosome Concentrations in Pathological Pregnancies
A completed clinical trial investigating free DNA and nucleosome concentrations in pathological pregnancies and associated pregnancy-related…
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: Comparison of Two Pulmonary Embolism Treatments [NA]
A completed clinical trial comparing two treatments for acute pulmonary embolism sponsored by Penumbra Inc.
-
CLINICAL_TRIALS trial_result · 2025-11-13Clinical Trial Update: The PEERLESS Study [NA]
The PEERLESS Study, sponsored by Inari Medical, has completed and posted results for pulmonary embolism; results were posted on 2025-11-13.
-
EMA approval · 2025-11-05EMA Authorised: Rivaroxaban Viatris (previously Rivaroxaban Mylan) (rivaroxaban) — Viatris Limited
The EMA authorised Viatris Limited to market rivaroxaban (brand name Rivaroxaban Viatris), expanding access to this anticoagulant as a gener…
-
CLINICAL_TRIALS research · 2025-11-04Clinical Trial Update: Validation of SEARCH, a Novel Hierarchical Algorithm to Define Long-term Outcomes After Pulmonary Embolism
Updates on validation of SEARCH, a new hierarchical algorithm designed to define long-term outcomes after pulmonary embolism.
-
CLINICAL_TRIALS research · 2025-10-29Clinical Trial Update: Clinical Utility of Portable Dynamic Chest X Ray (DDR) in the ICU [NA]
A clinical trial update indicates the portable dynamic chest X-ray (DDR) is being evaluated for ICU use, with the study currently recruiting…
-
CLINICAL_TRIALS research · 2025-10-15Clinical Trial Update: Epidemiology of Venous Thrombosis and Pulmonary Embolism
This Clinical Trial update reports on the epidemiology of venous thromboembolism and pulmonary embolism, sponsored by the University of Minn…
-
FDA approval · 2025-10-07FDA Approved: RIVAROXABAN — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approves Sun Pharmaceutical's generic rivaroxaban under an original ANDA, for the same indications as the reference product (e.g., reduc…
-
CLINICAL_TRIALS trial_result · 2025-10-02Clinical Trial Update: Home Rehabilitation After Acute Pulmonary Embolism [NA]
A clinical trial evaluating home rehabilitation after an acute pulmonary embolism has completed.
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST) [NA]
Clinical Trial Update: TRUST study evaluating the Laguna Thrombectomy System for treating pulmonary embolism; currently recruiting.